What does the RSU award to Myriam Curet cost per share at Inspire Medical (INSP)?

The RSU award to Myriam Curet carries a stated price of $0.00 per share. This reflects a typical equity compensation grant, where shares are received upon vesting rather than purchased in an open-market transaction.

Director at Inspire Medical (INSP) receives 3,562 RSU equity award

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Curet Myriam reported acquisition or exercise transactions in this Form 4 filing.

Inspire Medical Systems director Myriam Curet received an equity award in the form of restricted stock units. She was granted 3,562 RSUs of common stock at no purchase price, each representing the right to receive one share when vested. The RSUs vest on the earlier of the first anniversary of the grant date or immediately before a Change of Control under the company’s 2018 Incentive Award Plan, if she continues serving the company through that date. Following this award, she directly holds 6,927 shares of Inspire Medical Systems common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Curet Myriam

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,562	$0.00	--

Holdings After Transaction: Common Stock — 6,927 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

RSU grant size: 3,562 RSUs Post-award holdings: 6,927 shares RSU grant price: $0.00 per share

3 metrics

RSU grant size 3,562 RSUs Award of Restricted Stock Units to director Myriam Curet

Post-award holdings 6,927 shares Common stock directly held after the RSU grant

RSU grant price $0.00 per share Stated price per share for the RSU equity award

Key Terms

Restricted Stock Units, Change of Control, 2018 Incentive Award Plan

3 terms

Restricted Stock Units financial

"Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Change of Control financial

"earlier to occur of (a) the first anniversary ... or (b) the date that is immediately prior to the occurrence of a Change of Control"

A change of control occurs when the ownership or management of a company shifts significantly, such as through a sale, merger, or acquisition, resulting in new leadership or ownership structure. This change can impact the company's direction and decision-making, which is important for investors because it may affect the company's stability, strategy, and future prospects.

2018 Incentive Award Plan financial

"Change of Control (as defined in the Issuer's 2018 Incentive Award Plan)"

Form 4 Insider Transactions: What Each Field Means →

05/04/2026 - 06:22 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Curet Myriam

(Last)

(First)

(Middle)

C/O INSPIRE MEDICAL SYSTEMS, INC.

5500 WAYZATA BLVD., SUITE 1600

(Street)

GOLDEN VALLEY

MINNESOTA

55416

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Inspire Medical Systems, Inc. [ INSP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/30/2026		A		3,562⁽¹⁾	A	$0	6,927	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.

	/s/ Bryan Phillips, Attorney-in-Fact for Myriam J. Curet, M.D.	05/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Inspire Medical Systems (INSP) report for Myriam Curet?

Inspire Medical Systems reported that director Myriam Curet received a grant of 3,562 Restricted Stock Units. Each RSU represents a right to receive one share of common stock if vesting conditions tied to time or a Change of Control are met.

How many Inspire Medical (INSP) shares does Myriam Curet hold after this Form 4 transaction?

After the RSU award, Myriam Curet is shown holding 6,927 shares of Inspire Medical Systems common stock directly. This reflects her position following the 3,562-unit Restricted Stock Unit grant reported in the Form 4 filing.

When do Myriam Curet’s 3,562 RSUs in Inspire Medical (INSP) vest?

The 3,562 RSUs vest on the earlier of the first anniversary of the grant date or immediately before a Change of Control, as defined in Inspire Medical’s 2018 Incentive Award Plan, assuming Myriam Curet continues her service with the company through that vesting date.

Is Myriam Curet’s transaction in Inspire Medical (INSP) an open-market purchase or sale?

The filing describes the transaction as a grant or award acquisition of 3,562 RSUs, not an open-market buy or sell. It is equity compensation, contingent on vesting conditions, rather than a discretionary stock trade executed in the market.